melphalan and Scleroderma--Localized

melphalan has been researched along with Scleroderma--Localized* in 2 studies

Other Studies

2 other study(ies) available for melphalan and Scleroderma--Localized

Article	Year
Reticulate scleroderma after isolated limb perfusion with melphalan. Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:6 Topics: Adult; Antineoplastic Agents, Alkylating; Humans; Leg Ulcer; Male; Melanoma; Melphalan; Middle Aged; Perfusion; Sarcoma; Scleroderma, Localized	1998
[Arndt-Gottron scleromyxedema and associated phenomena]. Dermatologica, 1984, Volume: 169, Issue:1 Scleromyxedema is an uncommon fibromucinous connective tissue disease characterized by accumulation of mucinous material in the dermis. A monoclonal paraprotein is regularly identified. A review of the literature (57 cases) shows the exceptional association of scleromyxedema with multiple myeloma (8.7%) and macroglobulinemia Waldenström (3.5%). A man with scleromyxedema, IgG lambda paraproteinemia, and sclerodactylia--as a special sign of scleromyxedema--is reported. Melphalan is the drug of choice in serious cases, but not effective in sclerodactylia. Topics: Fingers; Humans; Hypergammaglobulinemia; Immunoglobulin G; Male; Melphalan; Microscopy, Electron; Middle Aged; Multiple Myeloma; Paraproteinemias; Scleroderma, Localized; Skin; Skin Diseases; Syndrome; Waldenstrom Macroglobulinemia	1984

Article

Year

Reticulate scleroderma after isolated limb perfusion with melphalan.

Journal of the American Academy of Dermatology, 1998, Volume: 39, Issue:6

Topics: Adult; Antineoplastic Agents, Alkylating; Humans; Leg Ulcer; Male; Melanoma; Melphalan; Middle Aged; Perfusion; Sarcoma; Scleroderma, Localized

1998

[Arndt-Gottron scleromyxedema and associated phenomena].

Dermatologica, 1984, Volume: 169, Issue:1

Scleromyxedema is an uncommon fibromucinous connective tissue disease characterized by accumulation of mucinous material in the dermis. A monoclonal paraprotein is regularly identified. A review of the literature (57 cases) shows the exceptional association of scleromyxedema with multiple myeloma (8.7%) and macroglobulinemia Waldenström (3.5%). A man with scleromyxedema, IgG lambda paraproteinemia, and sclerodactylia--as a special sign of scleromyxedema--is reported. Melphalan is the drug of choice in serious cases, but not effective in sclerodactylia.

Topics: Fingers; Humans; Hypergammaglobulinemia; Immunoglobulin G; Male; Melphalan; Microscopy, Electron; Middle Aged; Multiple Myeloma; Paraproteinemias; Scleroderma, Localized; Skin; Skin Diseases; Syndrome; Waldenstrom Macroglobulinemia

1984